Oskar Hoff

Company: Celeris Therapeutics

Job title: Head of Medicinal Chemistry

Seminars:

Data-Driven Design Of Small Molecule Protein Degraders – Utilising Deep Learning To Streamline Drug Development 1:30 pm

Heterobifunctional degraders to hijack E3 ligases Machine learning models leading to ternary complex prediction Synthesis and in vitro screening of selected candidatesRead more

day: Day 2 PM - Stream A